Equity Analysis of Selected Small cap stocks listed in BSE
Suresh A.S.1, Srinivas Bandi.2
Mr. Suresh A.S. Research scholar, Associate Professor, ISBR Research Centre, ISBR Research Centre, University of Mysore.
Dr. Srinivas Bandi. Research scholar, Associate Professor, ISBR Research Centre, ISBR Research Centre, University of Mysore.
Manuscript received on 2 August 2019. | Revised Manuscript received on 11 August 2019. | Manuscript published on 30 September 2019. | PP: 1551-1554 | Volume-8 Issue-3 September 2019 | Retrieval Number: C4267098319/2019©BEIESP | DOI: 10.35940/ijrte.C4267.098319
Open Access | Ethics and Policies | Cite | Mendeley | Indexing and Abstracting
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Abstract: The research paper is organized to analyze the risk and return of selected small cap stocks listed on BSE and also to compare the performance of each stock against the benchmark. The data is collected for a period of 5 years i.e., from 1st January 2014 to 31st December 2018. The paper compares the performance of each stock taking BSE Small cap index as benchmark. The study is purely based on secondary data collected from BSE. The data were collected based on monthly prices of the selected small cap stocks, and with the help of monthly prices annual return were calculated for a period of 5 years. The study shows that Aarti drugs, Wintac pharmaceuticals and TATA Elxsi have given highest returns during the study period. Whereas the return of DCB bank is lowest during the same period. The beta of all the stocks are positive except TATA Elxsi, indicating that all the shares carry a higher risk.
Keyword: Benchmark, BSE, returns, risk, small cap.
Scope of the Article: Predictive Analysis